Apriori Bio, a Boston, MA-based biotechnology company providing innovations against viral threats, raised US $1.1M in funding.
CEPI made the investment.
The company intends to use the funds to biology-informed artificial intelligence platform Octavia™.
Led by CEO Lovisa…
[ad_2]
Source link
